Aytu Biopharma (AYTU) Share-based Compensation Growth (1y) (2015 - 2025)
Aytu Biopharma (AYTU) Share-based Compensation Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | 6.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87.42% |
| Sep 30, 2025 | -34.10% |
| Jun 30, 2025 | -67.90% |
| Dec 31, 2024 | -81.59% |
| Sep 30, 2024 | -81.40% |
| Jun 30, 2024 | -60.89% |
| Mar 31, 2024 | -10.09% |
| Dec 31, 2023 | -73.26% |
| Sep 30, 2023 | -20.99% |
| Jun 30, 2023 | -26.83% |
| Mar 31, 2023 | -28.98% |
| Dec 31, 2022 | 149.55% |
| Sep 30, 2022 | -22.51% |
| Jun 30, 2022 | 0.08% |
| Dec 31, 2021 | 141.93% |
| Sep 30, 2021 | 233.85% |
| Jun 30, 2021 | 151.75% |
| Dec 31, 2020 | 217.50% |
| Sep 30, 2020 | 175.76% |
| Jun 30, 2020 | 63.18% |